Children's Corporate Center

Wauwatosa, Wisconsin 53226

0 studies enrolling now · 2 studies all time

What they study most

Respiratory Syncytial Virus Infections

Studies at this site

• Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children — Completed
• Study to Evaluate the Incidence of Hospitalizations and Respiratory Tract Infections in Premature Infants — Completed